Serplulimab
Product Specifications
CAS Number
2231029-82-4
Target
PD-1/PD-L1|||COX|||STAT|||Akt
Related Pathways
Cell Cycle/Checkpoint|||Stem Cells|||Immunology/Inflammation|||Apoptosis|||Cytoskeletal Signaling|||PI3K/Akt/mTOR signaling|||JAK/STAT signaling|||Neuroscience
Purity
>95%
Bioactivity
Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1387270-01 0.02 mg (E-Coli)
Recombinant Mycobacterium tuberculosis Putative transposase Rv3428c (Rv3428c)
Ask
View Details MBS1387270-02 0.02 mg (Yeast)
Recombinant Mycobacterium tuberculosis Putative transposase Rv3428c (Rv3428c)
Ask
View Details MBS1387270-03 0.1 mg (E-Coli)
Recombinant Mycobacterium tuberculosis Putative transposase Rv3428c (Rv3428c)
Ask
View Details 
MBS1387270-04 0.1 mg (Yeast)
Recombinant Mycobacterium tuberculosis Putative transposase Rv3428c (Rv3428c)
Ask
View Details MBS1387270-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium tuberculosis Putative transposase Rv3428c (Rv3428c)
Ask
View Details